A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- OBSERVATIONAL
- Evidence population
- Human clinical study registration
- Participants
- 25
- Population
- ALL · 65 Years
- Duration
- 2022-05-02 to 2025-06-13
- Intervention
- Geriatric Assessments and Frailty Indices
- Comparator
- Not reported
- Outcomes measured
- Resiliency Administered Assessments - Change of Short Physical Performance Battery (SPPB) — At baseline, 3 months and 6…; Resiliency Administered Assessments - Change of Grip Strength — At baseline, 3 months and 6 months after chemotherapy; Resiliency Administered Assessments - Change of Blessed Orientation Memory and Concentration Test (BOMC) — At baseline,…; Change of Electronic Frailty Index and Cancer Score/Category — At baseline, 3 months and 6 months after chemotherapy; Change in Patient Reported Outcomes Measurement - PROMIS 29 — At baseline, 3 months and 6 months after chemotherapy; Change of Biomarkers of Aging Observed During Study Intervention — At baseline, 3 months and 6 months after chemotherapy; Number of Incidences of Toxicity - Grades 2 to 5 Related to Standard of Care Chemotherapy — Up to 6 months after chemot…; Number of Documented Dose Reductions During Chemotherapy — Up to 6 months after chemotherapy; Number of Dose Delays During Chemotherapy — Up to 6 months after chemotherapy; Number of Early Discontinuations of Chemotherapy — Up to 6 months after chemotherapy; Number of Unplanned Hospitalizations — Up to 6 months after chemotherapy; Overall Survival — Up to 6 months after chemotherapy
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Frailty · 100%Title contains controlled term: frailty. Source terminology contains: frailty. Title supplies longevity context: aging, frailty. Study type is explicitly identified as OBSERVATIONAL.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.
